RESUMO
Functionalization can change the physicochemical properties of hydrochar and improve its ability to adsorb pollutants. Herein, a trithiocyanurate-functionalized hydrochar (TTHC) was obtained from acylation of chloroacetyl chloride and hydrochar and modification with trithiocyanuric acid in alkaline conditions. TTHC can efficiently remove cationic methylene blue (MB) and Pb(II) from wastewater. The removal can be expressed with pseudo-second-order kinetic and Langmuir models. The MB and Pb(II) removed uptakes by TTHC at 298 K exceeded 909.9 and 182.8 mg g-1 respectively, and the removal rates reached 90% and 98% within 120 min respectively. Characterizations show TTHC is functionalized with trithiocyanurate, and rich in thiolate and aromaticity, and tends to adsorb MB/Pb(II) via multiple adsorption mechanisms. After five sorption-desorption regeneration cycles, TTHC maintained 80% and 99% adsorption capacities for MB and Pb(II) respectively. Therefore, TTHC is a promising efficient sorbent for removing MB and Pb(II) from effluents.
Assuntos
Poluentes Ambientais , Poluentes Químicos da Água , Poluentes Químicos da Água/análise , Azul de Metileno/química , Chumbo , Águas Residuárias , Adsorção , CinéticaRESUMO
Hedyotis Diffusa Willd (HDW), a Chinese herbal medicine, has been widely used as an adjuvant therapy against various cancers, including hepatocellular carcinoma (HCC). However, the underlying anticancer mechanisms are yet to be elucidated. In the present study, the anticancer effects of HDW were evaluated and the efficacy and safety of HDW combined with low-dose 5-fluorouracil (5-FU) were investigated. HepG2 cells were cultured in vitro and nude mouse xenografts were established in vivo. The proliferation of HepG2 cells was measured using the MTT method and flow cytometry. The mRNA and protein expression levels of cyclin-dependent kinase 2 (CDK2), cyclin E and E2F1 were examined using relative quantitative real-time PCR and western blot analysis, respectively. The results showed that water extract of HDW remarkably inhibited HepG2 cell proliferation in a dose-dependent manner via arrest of HepG2 cells at the G0/G1 phase and induction of S phase delay. This suppression was accompanied by a great decrease of E2F1 and CDK2 mRNA expression. In addition, HDW remarkably potentiated the anticancer effect of low-dose 5-FU in the absence of overt toxicity by downregulating the mRNA and protein levels of CDK2, cyclin E and E2F1. Our findings support the use of HDW as adjuvant therapy of chemotherapy and suggest that HDW may potentiate the efficiency of low-dose 5-FU in treating HCC.